From Today's PR - at least we were not told "no" y
Post# of 36503
![](/assets/46931549/no_avatar_available_thumb.jpg)
Mr. Moscato continued, “With the explosion of the SARS-CoV-2 pandemic, we restarted the pandemic vaccine development program conducted by NGIO from 2004 to 2010 and submitted proposals to government agencies and international organizations to fund the development of a COVID-19 vaccine. As we await the funding decisions, we continue to advance the Ii-Key-SARS-CoV-2 peptide vaccine initiative.
https://www.biospace.com/article/releases/nug...e-vaccine/
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)